This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (19)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Cardiovascular System  • Cardiovascular Disease/ Myocardial Infarction  • Diabetes Mellitus  • Alert me on articles by topic  Social Bookmarking   What's this?

Oscar H. Franco, MD, DSc, PhD; Ewout W. Steyerberg, PhD; Frank B. Hu, MD, PhD; Johan Mackenbach, MD, PhD; Wilma Nusselder, PhD

Arch Intern Med. 2007;167(11):1145-1151.

Background  Diabetes mellitus is a recognized risk factor for cardiovascular disease (CVD) and mortality. However, limited information exists on the association of diabetes with life expectancy with and without CVD. We aimed to calculate the association of diabetes after age 50 years with life expectancy and the number of years lived with and without CVD.

Methods  Using data from the Framingham Heart Study, we built life tables to calculate the associations of having diabetes with life expectancy and years lived with and without CVD among populations 50 years and older. For the life table calculations, we used hazard ratios for 3 transitions (healthy to death, healthy to CVD, and CVD to death), stratifying by the presence of diabetes at baseline and adjusting for age and confounders.

Results  Having diabetes significantly increased the risk of developing CVD (hazard ratio, 2.5 for women and 2.4 for men) and of dying when CVD was present (hazard ratio, 2.2 for women and 1.7 for men). Diabetic men and women 50 years and older lived on average 7.5 (95% confidence interval, 5.5-9.5) and 8.2 (95% confidence interval, 6.1-10.4) years less than their nondiabetic equivalents. The differences in life expectancy free of CVD were 7.8 and 8.4 years, respectively.

Conclusions  The increase in the risk of CVD and mortality from diabetes represents an important decrease in life expectancy and life expectancy free of CVD. Prevention of diabetes is a fundamental task facing today's society in the pursuit of healthy aging.

Author Affiliations: Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands (Drs Franco, Steyerberg, Mackenbach, and Nusselder); Unilever Corporate Research, Colworth House, Sharnbrook, England (Dr Franco); Departments of Nutrition and Epidemiology, Harvard School of Public Health, the Channing Laboratory, Brigham and Women's Hospital, and Harvard Medical School, Boston, Mass (Dr Hu).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Dysglycemia and acute myocardial infarction the role of echocardiography.
Verhaert and Thomas
J Am Coll Cardiol Img 2009;2:600-603.
FULL TEXT  

Macrovascular Complications of Diabetes Mellitus
Nuzum and Merz
Journal of Pharmacy Practice 2009;22:135-148.
ABSTRACT  

Is Relative Mortality of Type 2 Diabetes Mellitus Decreasing?
Gulliford and Charlton
Am J Epidemiol 2009;169:455-461.
ABSTRACT | FULL TEXT  

Heart Disease and Stroke Statistics--2009 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
WRITING GROUP MEMBERS et al.
Circulation 2009;119:e21-e181.
FULL TEXT  

Mortality Rates and Diabetic Foot Ulcers: Is it Time to Communicate Mortality Risk to Patients with Diabetic Foot Ulceration?
Robbins et al.
J. Am. Podiatr. Med. Assoc. 2008;98:489-493.
ABSTRACT | FULL TEXT  

Low-Fat Dietary Pattern and Risk of Treated Diabetes Mellitus in Postmenopausal Women: The Women's Health Initiative Randomized Controlled Dietary Modification Trial
Tinker et al.
Arch Intern Med 2008;168:1500-1511.
ABSTRACT | FULL TEXT  

PROactive: time for a critical appraisal
Betteridge et al.
Eur Heart J 2008;29:969-983.
ABSTRACT | FULL TEXT  

Modulation of 11{beta}-Hydroxysteroid Dehydrogenase (11{beta}HSD) Activity Biomarkers and Pharmacokinetics of PF-00915275, a Selective 11{beta}HSD1 Inhibitor
Courtney et al.
J. Clin. Endocrinol. Metab. 2008;93:550-556.
ABSTRACT | FULL TEXT  

Heart Disease and Stroke Statistics--2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Writing Group Members et al.
Circulation 2008;117:e25-e146.
FULL TEXT  

Diabetes and Mortality Following Acute Coronary Syndromes
Donahoe et al.
JAMA 2007;298:765-775.
ABSTRACT | FULL TEXT